These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30181608)

  • 21. Regulation of Wnt/β-catenin signaling within and from osteocytes.
    Burgers TA; Williams BO
    Bone; 2013 Jun; 54(2):244-9. PubMed ID: 23470835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches.
    Canalis E
    Nat Rev Endocrinol; 2013 Oct; 9(10):575-83. PubMed ID: 23938284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of anabolic therapies for osteoporosis.
    Canalis E; Giustina A; Bilezikian JP
    N Engl J Med; 2007 Aug; 357(9):905-16. PubMed ID: 17761594
    [No Abstract]   [Full Text] [Related]  

  • 24. Potential role for therapies targeting DKK1, LRP5, and serotonin in the treatment of osteoporosis.
    Zhang W; Drake MT
    Curr Osteoporos Rep; 2012 Mar; 10(1):93-100. PubMed ID: 22210558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoblasts in osteoporosis: past, emerging, and future anabolic targets.
    Marie PJ; Kassem M
    Eur J Endocrinol; 2011 Jul; 165(1):1-10. PubMed ID: 21543379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update in new anabolic therapies for osteoporosis.
    Canalis E
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1496-504. PubMed ID: 20375217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The future of osteoporosis treatment - a research update.
    Lippuner K
    Swiss Med Wkly; 2012; 142():w13624. PubMed ID: 22815185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wnt signaling and potential applications in bone diseases.
    Rawadi G
    Curr Drug Targets; 2008 Jul; 9(7):581-90. PubMed ID: 18673244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting sclerostin as potential treatment of osteoporosis.
    Papapoulos SE
    Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i119-22. PubMed ID: 21339215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New therapeutics for osteoporosis.
    Ng KW; Martin TJ
    Curr Opin Pharmacol; 2014 Jun; 16():58-63. PubMed ID: 24699340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseases.
    Boudin E; Fijalkowski I; Piters E; Van Hul W
    Semin Arthritis Rheum; 2013 Oct; 43(2):220-40. PubMed ID: 23433961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging therapeutic targets for osteoporosis treatment.
    Chen M; Qiao H; Su Z; Li H; Ping Q; Zong L
    Expert Opin Ther Targets; 2014 Jul; 18(7):817-31. PubMed ID: 24766518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic innovation in osteoporosis (antisclerostin antibody and denosumab)].
    Quemerais-Durieu MA; Kerlan V; Chabre O
    Ann Endocrinol (Paris); 2011 Oct; 72 Suppl 1():S15-22. PubMed ID: 22008272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bi-directionally selective bone targeting delivery for anabolic and antiresorptive drugs: a novel combined therapy for osteoporosis?
    Liu J; Zhang H; Dong Y; Jin Y; Hu X; Cai K; Ma J; Wu G
    Med Hypotheses; 2014 Dec; 83(6):694-6. PubMed ID: 25459136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Approaches To Identifying Novel Osteoporosis Drug Targets.
    Brommage R
    J Cell Biochem; 2015 Oct; 116(10):2139-45. PubMed ID: 25833316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans.
    Aslan D; Andersen MD; Gede LB; de Franca TK; Jørgensen SR; Schwarz P; Jørgensen NR
    Scand J Clin Lab Invest; 2012 Feb; 72(1):14-22. PubMed ID: 22085136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sialoglycoprotein Isolated from Eggs of Carassius auratus Ameliorates Osteoporosis: An Effect Associated with Regulation of the Wnt/β-Catenin Pathway in Rodents.
    Wang F; Wang Y; Zhao Y; Zhan Q; Yu P; Wang J; Xue C
    J Agric Food Chem; 2016 Apr; 64(14):2875-82. PubMed ID: 27023001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Research Progress on the Mechanism of the SFRP-Mediated Wnt Signalling Pathway Involved in Bone Metabolism in Osteoporosis.
    An F; Song J; Chang W; Zhang J; Gao P; Wang Y; Xiao Z; Yan C
    Mol Biotechnol; 2024 May; 66(5):975-990. PubMed ID: 38194214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sclerostin Inhibition in the Management of Osteoporosis.
    Appelman-Dijkstra NM; Papapoulos SE
    Calcif Tissue Int; 2016 Apr; 98(4):370-80. PubMed ID: 27016922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigational anabolic therapies for osteoporosis.
    Trivedi R; Goswami R; Chattopadhyay N
    Expert Opin Investig Drugs; 2010 Aug; 19(8):995-1005. PubMed ID: 20629616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.